Study Information
| Title: | An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study  |
| Status: | Recruiting participants |
| Conditions: | Chronic Lymphocytic Leukemia; Lymphoma, Non-Hodgkin; Acute Myeloid Leukemia; Multiple Myeloma |
| Interventions: | Drug: CAL-101 |
| Institutions: | Dana-Farber Cancer Institute |
| Health Topics: | Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Non-Hodgkin Lymphoma |
Contact Information
Dana-Farber Cancer Institute
Boston, MA 02115
Katie Mullins
617-582-8713
KatherineA_Mullins@DFCI.HARVARD.EDU